599PEfficacy and safety of a recombinant soluble human thrombomodulin (ART-123) in preventing oxaliplatin induced peripheral neuropathy (OIPN): Results of a placebo-controlled, randomized, double-blind phase II study. (23rd October 2018) - Kato, T; Kotaka, M; Satake, H; Makiyama, A; Tsuji, Y; Shinozaki, K; Fujiwara, T; Mizushima, T; Harihara, Y; Nagata, N; Kurihara, N; Kagawa, Y; et al.